SMALL heart size is linked to higher mortality risk in individuals with normal ejection fraction , particularly in women and those with high-normal ejection fraction.
Bayer seeks European marketing approval for use of finerenone in adult patients with HF with a left ventricular ejection fraction (LVEF) of =40%: Berlin Tuesday, February 4, 2025, ...
Finerenone is the first drug targeting the mineralocorticoid receptor (MR) pathway to demonstrate cardiovascular benefits in a Phase III study in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback